Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Althea Technologies, a contract development and manufacturing firm, has obtained license from the US Food and Drug administration (FDA) to manufacture and package a commercial parenteral product for the US market.
Subscribe to our email newsletter
The FDA’s decision follows a Pre-Approval Inspection (PAI) which was done in April 2011 by the US regulators.
The company expects to do the filling and packaging of the product in its San Diego-based California manufacturing plant.
Althea president Rick Hancock said they anticipate working with their clients to bring several other products to commercialization over the coming months.